Photo taken from IASLC/X
Jul 4, 2024, 11:48
The Importance of Waiting for Biomarker Results in NSCLC
IASLC (International Association for the Study of Lung Cancer) shared a post on X:
“Biomarkers are essential in lung cancer treatment. Clinicians and patients have to wait for results before starting therapy. Stephen V Liu guides a discussion about biomarkers, and challenges/issues they create. With guests Ilit Turgeman, Dr. Mark Kris, and Aurora Lucas.”
Proceed to the discussion.
Source: IASLC/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12